Expression and polimorphism of IFN-γ gene in patients with cervical cancer

Experimental Oncology

Volumn 30, Issue 3, 2008, Pages 224-229

  Tamandani, M K Kordi ^a   Sobti, R C ^a   Shekari, M ^a   Mukesh, M ^b   Suri, V ^c  

^a PANJAB UNIVERSITY   (India)

^b NATIONAL BUREAU OF ANIMAL GENETIC RESOURCES   (India)

^c POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Cervical cancer; Expression; IFN gene; Polymorphism

Indexed keywords

GAMMA INTERFERON; MESSENGER RNA;

ADULT; ALLELE; ARTICLE; BLOOD; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; DNA ISOLATION; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PASSIVE SMOKING; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADOLESCENT; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; INTERFERON-GAMMA; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER; RNA, NEOPLASM; UTERINE CERVICAL NEOPLASMS;

EID: 53649103144     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Shanta V, Krishnamurthi S, Gajalakshmi CK, et al. Epidemiology of cancer of the cervix: global and national perspective. J Indian Med Assoc 2000;98: 49-52.
2. Syrja'nen KJ, Syrjänen SM, Molecular biology of papillomaviruses. In: Syrjänen KJ, Syrjänen SM, eds. Papillomavirus infections in human pathology. John Wiley & Sons, Ltd, Chichester, NY: 2000; 11-51.
3. Wu TC, Immunology of the human papillomavirus in relation to cancer. Curr Opin Immunol 1994;6: 746-54.
4. Song SH, Lee JK, Lee XW, et al. Interferon-gamma (IFN-gamma): a possible prognostic marker for clearance of high-risk human papillomavirus (HPV). Gynecol Oncol 2008;108: 543-8.
5. Ivashkiv BL, Hu X, Signaling by STATs. Arthritis Res Ther 2004;6: 159-68.
6. Calvo J, Martínez X, Etxagibel A, et al. Allelic frequencies of polymorphic varíants of cytokine genes (IL IA, IL IB, IL1RN, IL6, IL10,1L 12p40, and IFNG) in a Spanish population. Immunologia 2002;21: 76-86.
7. Matos GI, Coras Cde J, Bittar Rde C, et al. IFNγ+874T/A polymorphism is not associated with American tegumentary leishmaniasis susceptibility but can influence Leishmania induced IFN-gamma production. BMC Infect Dis 2007;7:33.
8. Gey A, Kumari P, Sambandam A, et al. Identification and characterization of a group of cervical carcinoma patients with profound downregulation of intratumoral Type 1 (IFNgamma) and Type 2 (IL-4) cytokine mRNA expression. Eur J Cancer 2003;39: 595-603.
9. Coussens LM, Werb Z, Inflammation and cancer. Nature 2002;420: 860-7.
10. Shacter E, Weitzman SA, Chronic inflammation and cancer. Oncology 2002;16: 217-29.
11. Pravica V, Asderakis A, Perrey C, et al. In vitro production of 1FN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet 1999;26:1-3.
12. Sharma A, Rajappa M, Saxena A, et al. Cytokine profile in Indian women with cervical intraepithelial neoplasia and cancer cervix. Int J Gynecol Cancer 2007;17: 879-85.
13. Wang RF, Miyahara Y, Wang HY, Toll-like receptors and immune regulation: implications for cancer therapy. Oncogene 2008;27: 181-9.
14. Etokebe GE, Bulat-Kardum L, Johansen MS, et al. Interferon-gamma gene (T874A and G2109A) polymorphisms are associated with microscopy-positive tuberculosis. Scand J Immunol 2006;63: 136-41.
15. Zambon CF, Basso D, Navaglia F, et al. Pro- and antiinflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine 2005;29: 141-52.
16. Roc BA, Crabtree JS, Khan AS, Methods for DNA isolation. Part III. In: DNA isolation and sequencing; New York: Wiley. 1996.
17. Lees DM, Khan NQ, Barker S, et al. Quantitative measurement of mRNA levels by RT-PCR. Studies of ECE-1 isoforms. Methods Mol Biol 2002;206: 125-45.
18. Pravica V, Perrey C, Stevens A, et al. Asingle nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 2000;61: 863-6.
19. Govan VA, Carrara HR, Sachs JA, et al. Ethnic differences in allelic distribution of IFN-gamma in South African women but no link with cervical cancer. J Carcinogen 2003;2: 3.
20. Lai HC, Chang CC, Lin YW, et al. Genetic polymorphism of the interferon-gamma gene in cervical carcinogenesis. Int J Cancer 2005;113:712-8.
21. Scola L, Vaglica M, Crivello A, et al. Cytokine gene polymorphisms and breast cancer susceptibility. Ann N YAcad Sci 2006;1089: 104-9.
22. Song HK, Yoon DY, Kang CJ, et al. EnhancedIL-18expression in common skin tumors. Immunol Lett 2001;79:215-9.
23. Dalgleish Ag and O'Byrne KJ, Chronic immune activation and inflammation in the pathogenesis of AIDS and cancer. Adv Cancer Res 2002;84: 231-76.
24. Shacter E, Weitzman SA, Chronic inflammation and cancer. Oncology 2002;16: 217-29.
25. Smith JS, Herrero R, Bosetti C, et al. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst 2002;94: 1604-13.
26. Ueda M, Hung YC, Terai Y, et al. Fas gene promoter -670 polymorphism (A/G) is associated with cervical carcinogenesis. Gynecol Oncol 2005;98: 129-33.
27. Tartour E, Gey A, Sastre-Garau X, et al. Prognostic value of intratumoral interferon gamma messenger RNA expression in invasive cervical carcinomas. J Natl Cancer Inst 1998;90: 287-94.
28. Ghosh P, Komschlies KL, Cippitelli M, et al. Gradual loss of T-helper 1 populations in spleen of mice during progressive tumor growth. J Natl Cancer Inst 1995;87: 1478-83.
29. Nakagomi H, Pisa P, Pisa EK, et al. Lack of interlcukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma. Int J Cancer 1995;63: 366-71.
30. Li J, Yu B, Song L, et al. Effects of IFN-gamma and Statl on gene expression, growth, and survival in non-small cell lung cancer cells. J Interferon Cytokine Res 2007;27: 209-20.
31. Pao CC, Yao DS, Lin CY, et al. Genomic aberrations of human apillomavirus recovered from cervical cancers. Biochem Biophys Res Commun 1996;222: 116-20.
32. Clerici M, Merola M, Ferrario E, et al. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J Natl Cancer Inst 1997;89: 245-50.
33. Handel-Fernandez ME, Cheng X, Herbert LM, et al. Downregulation of IL-12, not ashift from a T helper-1 to a T helper-2 phenotype is responsible for impaired IFN-gamma production in mammary tumor bearing mice. J Immunol 1997;158: 280-6.
34. Pao CC, Yao DS, Lin CY, et al. Genomic aberrations of human apillomavirus recovered from cervical cancers. Biochem Biophys Res Commun 1996: 222: 116-20.
35. Tartour E, Gey A, Sastre-Garau X, et al. Prognostic value of intratumoral interferon gamma messenger RNA expression in invasive cervical carcinomas. J Natl Cancer Inst 1998;90: 287-94.